| 摘要 |
<p>Drug compositions containing as the active ingredient compounds of general formula (I), prodrugs of the same, pharmaceutically acceptable salts of both, or solvates of them and exhibiting thrombopoietin receptor agonism: wherein X1 is optionally substituted heteroaryl or the like; Y?1 is NRA¿CO-(CH¿2?)0-2- or the like (wherein R?A¿ is hydrogen or the like); Z1 is optionally substituted allylene or the like; and A1 is a ring represented by general formula (II) or (III):</p> |
